# Cellomics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cellomics

- Industry: Healthcare
- Headquarters: Pittsburgh, US
- Website: www.cellomics.com
- Total disclosed funding: $50M
- Latest round: Series D (Feb 1, 2002)
- Investors on record: 10

## About

Cellomics, Inc. develops and markets high content screening systems for drug screening and localization within living cells.

## Funding rounds

- Series D, Feb 1, 2002, $20M — Oxford Bioscience Partners
- Series C, Oct 1, 2000, $30M — Alta Partners, Burrill & Company, InterWest Partners, Muzinich & Co, Vector Fund Management, Edmond de Rothschild Group, Amerindo Investment Advisors, BayStar Capital, BioSphere Medical

## Investors

- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series C
- Burrill & Company (https://capitalatlas.ai/funds/burrill-company) — Series C
- InterWest Partners (https://capitalatlas.ai/funds/interwest-partners) — Series C
- Muzinich & Co — Series C
- Vector Fund Management (https://capitalatlas.ai/funds/vector-fund-management) — Series C
- Edmond de Rothschild Group — Series C
- Amerindo Investment Advisors — Series C
- BayStar Capital (https://capitalatlas.ai/funds/baystar-capital) — Series C
- BioSphere Medical — Series C
- Oxford Bioscience Partners (https://capitalatlas.ai/funds/oxford-bioscience-partners) — Series D